Location History:
- Jeollanam-do, KR (2016)
- Incheon, KR (2018 - 2022)
Company Filing History:
Years Active: 2016-2024
Title: Innovations in Bacteriophage Therapy: The Patents of Hyoun Rok Paik
Introduction
Hyoun Rok Paik, based in Incheon, South Korea, is a prominent inventor specializing in bacteriophage research with a remarkable portfolio of 18 patents. His work primarily focuses on the development of innovative treatments that utilize bacteriophages, which are viruses that infect and kill bacteria, offering significant potential for combating antibiotic resistance and improving healthcare solutions.
Latest Patents
Among his latest patents, two notable inventions are the bacteriophage STP-2 and bacteriophage Clo-PEP-2. The invention concerning bacteriophage STP-2 (Accession number: KCTC 12853BP) highlights its ability to destroy harmful bacteria and presents a method for preventing and treating diseases associated with bacterial proliferation. This bacteriophage is characterized by a specific genome represented by SEQ ID NO:1.
Similarly, his work on bacteriophage Clo-PEP-2 (Accession number: KCTC 13185BP) emphasizes its capacity to eliminate bacteria and outlines a method for preventing or treating diseases caused by bacterial infections. This invention showcases the application of bacteriophage Clo-PEP-2 in therapeutic compositions, further advancing the field of bacteriophage therapy.
Career Highlights
Hyoun Rok Paik is currently associated with Intron Biotechnology, Inc., where his expertise is leveraged to push the boundaries of bacteriophage therapeutic applications. His contributions have considerably influenced the landscape of biological research and treatment methodologies, positioning him as a key innovator in the industry.
Collaborations
Throughout his career, Paik has collaborated with notable colleagues such as Seong Jun Yoon and Sang Hyeon Kang. These partnerships have facilitated the exchange of ideas and expertise, enhancing the research outcomes and leading to the development of his groundbreaking patents.
Conclusion
Hyoun Rok Paik’s innovative work in the field of bacteriophage therapy represents a significant advancement in medical science. With 18 patents to his name, his contributions to the development of bacteriophages like STP-2 and Clo-PEP-2 reflect his commitment to finding effective solutions to combat bacterial diseases. As research in this domain continues to evolve, Paik's inventions will likely play an instrumental role in shaping future therapeutic approaches.